Abiopharma

iRhythm Technologies to Participate in Upcoming Investor Conferences

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025

Anaptys Announces Participation in November Investor Conferences

Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update

Premier Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Premier, Inc. - PINC

Phibro Animal Health Corporation Declares Quarterly Dividend

Revolution Medicines to Participate in November 2025 Investor Conferences

Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements